Showing results (21-30 of 138) with videos related to

Sort By:
Pageof 14
Trends in Endocrinology and Metabolism: TEM|September 5, 2025
Biliverdin reductase-A is a key modulator in insulin signaling and metabolismAntonella Tramutola, Fabio Di Domenico, Marzia Perluigi, et al.
Biochimica Et Biophysica Acta|October 25, 2011
Circulating biomarkers of protein oxidation for Alzheimer disease: expectations within limitsFabio Di Domenico, Raffaella Coccia, D Allan Butterfield, et al.
CNS Drugs|August 15, 2019
Targeting Mitochondria in Alzheimer Disease: Rationale and PerspectivesChiara Lanzillotta, Fabio Di Domenico, Marzia Perluigi, et al.
Expert Review of Neurotherapeutics|September 23, 2014
Strategy to reduce free radical species in Alzheimer's disease: an update of selected antioxidantsFabio Di Domenico, Eugenio Barone, Marzia Perluigi, et al.
Antioxidants & Redox Signaling|September 15, 2016
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox ProteomicsFabio Di Domenico, Eugenio Barone, Marzia Perluigi, et al.
Free Radical Biology & Medicine|September 16, 2021
The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer diseaseEugenio Barone, Fabio Di Domenico, Marzia Perluigi, et al.
Free Radical Biology & Medicine|July 15, 2017
Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolismEugenio Barone, Andrea Arena, Elizabeth Head, et al.
Antioxidants (Basel, Switzerland)|May 4, 2026
Loss of Proteostasis and Early-Onset Neurodegeneration in Down Syndrome: From Mechanisms to InterventionsAntonella Tramutola, Chiara Lanzillotta, Fabio Di Domenico, et al.
Antioxidants (Basel, Switzerland)|August 26, 2020
The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and DementiaMarzia Perluigi, Antonella Tramutola, Sara Pagnotta, et al.
Frontiers in Neuroscience|August 1, 2020
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain DysfunctionsMara Dierssen, Marta Fructuoso, María Martínez de Lagrán, et al.
Pageof 14